
James D. Anderson
Examiner (ID: 12640, Phone: (571)272-9038 , Office: P/1629 )
| Most Active Art Unit | 1629 |
| Art Unit(s) | 1614, 1629 |
| Total Applications | 1668 |
| Issued Applications | 822 |
| Pending Applications | 121 |
| Abandoned Applications | 752 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16189267
[patent_doc_number] => 20200230116
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-23
[patent_title] => METHODS FOR RETREATING IRRITABLE BOWEL SYNDROME (IBS)
[patent_app_type] => utility
[patent_app_number] => 16/746089
[patent_app_country] => US
[patent_app_date] => 2020-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48218
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16746089
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/746089 | METHODS FOR RETREATING IRRITABLE BOWEL SYNDROME (IBS) | Jan 16, 2020 | Abandoned |
Array
(
[id] => 16183485
[patent_doc_number] => 10716777
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-21
[patent_title] => Antitumoral use of cabazitaxel
[patent_app_type] => utility
[patent_app_number] => 16/743411
[patent_app_country] => US
[patent_app_date] => 2020-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7040
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16743411
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/743411 | Antitumoral use of cabazitaxel | Jan 14, 2020 | Issued |
Array
(
[id] => 16189285
[patent_doc_number] => 20200230134
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-23
[patent_title] => PARP-1 AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/742625
[patent_app_country] => US
[patent_app_date] => 2020-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36746
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16742625
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/742625 | PARP-1 and methods of use thereof | Jan 13, 2020 | Issued |
Array
(
[id] => 17266362
[patent_doc_number] => 11191766
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-07
[patent_title] => Methods of treating pediatric cancers
[patent_app_type] => utility
[patent_app_number] => 16/739845
[patent_app_country] => US
[patent_app_date] => 2020-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 14
[patent_no_of_words] => 34906
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16739845
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/739845 | Methods of treating pediatric cancers | Jan 9, 2020 | Issued |
Array
(
[id] => 16108437
[patent_doc_number] => 20200206241
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-02
[patent_title] => PHARMACEUTICAL COMPOSITION FOR TREATMENT OF INCREASED INTRAOCULAR PRESSURE
[patent_app_type] => utility
[patent_app_number] => 16/731824
[patent_app_country] => US
[patent_app_date] => 2019-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6724
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16731824
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/731824 | Pharmaceutical composition for treatment of increased intraocular pressure | Dec 30, 2019 | Issued |
Array
(
[id] => 15828433
[patent_doc_number] => 20200129498
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-30
[patent_title] => COMBINATION THERAPY
[patent_app_type] => utility
[patent_app_number] => 16/730015
[patent_app_country] => US
[patent_app_date] => 2019-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15554
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16730015
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/730015 | Combination therapy | Dec 29, 2019 | Issued |
Array
(
[id] => 16397192
[patent_doc_number] => 20200338050
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-29
[patent_title] => Novel Dosing Regimens of Celgosivir for the Treatment of Dengue
[patent_app_type] => utility
[patent_app_number] => 16/725387
[patent_app_country] => US
[patent_app_date] => 2019-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15246
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16725387
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/725387 | Dosing regimens of celgosivir for the treatment of dengue | Dec 22, 2019 | Issued |
Array
(
[id] => 17043768
[patent_doc_number] => 11096927
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-24
[patent_title] => Anti-flavivirus compounds and methods of use
[patent_app_type] => utility
[patent_app_number] => 16/721221
[patent_app_country] => US
[patent_app_date] => 2019-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10763
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16721221
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/721221 | Anti-flavivirus compounds and methods of use | Dec 18, 2019 | Issued |
Array
(
[id] => 18477105
[patent_doc_number] => 11690829
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-04
[patent_title] => Use of gaboxadol for the treatment of non-24 hour sleep-wake disorder
[patent_app_type] => utility
[patent_app_number] => 16/717203
[patent_app_country] => US
[patent_app_date] => 2019-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 19363
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16717203
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/717203 | Use of gaboxadol for the treatment of non-24 hour sleep-wake disorder | Dec 16, 2019 | Issued |
Array
(
[id] => 15765611
[patent_doc_number] => 20200113823
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-16
[patent_title] => TABLETS WITH IMPROVED ACCEPTANCE AND GOOD STORAGE STABILITY
[patent_app_type] => utility
[patent_app_number] => 16/716205
[patent_app_country] => US
[patent_app_date] => 2019-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3884
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16716205
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/716205 | Tablets with improved acceptance and good storage stability | Dec 15, 2019 | Issued |
Array
(
[id] => 17192078
[patent_doc_number] => 11160807
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-11-02
[patent_title] => Methods, compositions and devices for treating cancer with illudofulvenes
[patent_app_type] => utility
[patent_app_number] => 16/708005
[patent_app_country] => US
[patent_app_date] => 2019-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 43862
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 707
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16708005
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/708005 | Methods, compositions and devices for treating cancer with illudofulvenes | Dec 8, 2019 | Issued |
Array
(
[id] => 17243395
[patent_doc_number] => 20210363138
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => SET8 LYSINE METHYLTRANSFERASE INHIBITOR AND PREPARATION METHOD AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/972454
[patent_app_country] => US
[patent_app_date] => 2019-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7022
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16972454
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/972454 | SET8 lysine methyltransferase inhibitor and preparation method and application thereof | Dec 4, 2019 | Issued |
Array
(
[id] => 16435614
[patent_doc_number] => 20200352939
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-12
[patent_title] => METHOD OF THERAPEUTIC ADMINISTRATION OF DHE TO ENABLE RAPID RELIEF OF MIGRAINE WHILE MINIMIZING SIDE EFFECT PROFILE
[patent_app_type] => utility
[patent_app_number] => 16/704867
[patent_app_country] => US
[patent_app_date] => 2019-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9404
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16704867
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/704867 | METHOD OF THERAPEUTIC ADMINISTRATION OF DHE TO ENABLE RAPID RELIEF OF MIGRAINE WHILE MINIMIZING SIDE EFFECT PROFILE | Dec 4, 2019 | Abandoned |
Array
(
[id] => 15708799
[patent_doc_number] => 20200101165
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-02
[patent_title] => COMPOSITE CONTAINING POLY(GLYCEROL SEBACATE) FILLER
[patent_app_type] => utility
[patent_app_number] => 16/702832
[patent_app_country] => US
[patent_app_date] => 2019-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6000
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16702832
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/702832 | COMPOSITE CONTAINING POLY(GLYCEROL SEBACATE) FILLER | Dec 3, 2019 | Abandoned |
Array
(
[id] => 15678257
[patent_doc_number] => 20200093792
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-26
[patent_title] => USE OF AMISULPRIDE AS AN ANTI-EMETIC
[patent_app_type] => utility
[patent_app_number] => 16/697986
[patent_app_country] => US
[patent_app_date] => 2019-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3569
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16697986
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/697986 | USE OF AMISULPRIDE AS AN ANTI-EMETIC | Nov 26, 2019 | Abandoned |
Array
(
[id] => 15678319
[patent_doc_number] => 20200093823
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-26
[patent_title] => METHOD OF TREATING BIPOLAR I AND II DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/695777
[patent_app_country] => US
[patent_app_date] => 2019-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4204
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16695777
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/695777 | METHOD OF TREATING BIPOLAR I AND II DISORDERS | Nov 25, 2019 | Abandoned |
Array
(
[id] => 17798995
[patent_doc_number] => 11413261
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-16
[patent_title] => Pharmaceutical composition for treating cancer comprising lactate metal salt
[patent_app_type] => utility
[patent_app_number] => 16/693218
[patent_app_country] => US
[patent_app_date] => 2019-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 86
[patent_no_of_words] => 21770
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16693218
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/693218 | Pharmaceutical composition for treating cancer comprising lactate metal salt | Nov 21, 2019 | Issued |
Array
(
[id] => 18178875
[patent_doc_number] => 20230039604
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 17/296055
[patent_app_country] => US
[patent_app_date] => 2019-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 62046
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -170
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17296055
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/296055 | Compositions and methods of modulating short-chain dehydrogenase activity | Nov 20, 2019 | Issued |
Array
(
[id] => 16837750
[patent_doc_number] => 20210145762
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => METHODS OF TREATING OXIDATIVE STRESS TO MODULATE REDOX BALANCE, PREVENTING OXIDATIVE STRESS INDUCED CELL DAMAGE AND DEATH
[patent_app_type] => utility
[patent_app_number] => 16/685729
[patent_app_country] => US
[patent_app_date] => 2019-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5379
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16685729
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/685729 | METHODS OF TREATING OXIDATIVE STRESS TO MODULATE REDOX BALANCE, PREVENTING OXIDATIVE STRESS INDUCED CELL DAMAGE AND DEATH | Nov 14, 2019 | Abandoned |
Array
(
[id] => 15553165
[patent_doc_number] => 20200060994
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-27
[patent_title] => METHODS OF TREATING PSYCHIATRIC STRESS DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/676495
[patent_app_country] => US
[patent_app_date] => 2019-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33088
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16676495
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/676495 | METHODS OF TREATING PSYCHIATRIC STRESS DISORDERS | Nov 6, 2019 | Abandoned |